Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study.
Saved in:
| Title: | Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study. |
|---|---|
| Authors: | Burge DJ; Trubion Pharmaceuticals Inc., Seattle, Washington, USA., Bookbinder SA, Kivitz AJ, Fleischmann RM, Shu C, Bannink J |
| Source: | Clinical therapeutics [Clin Ther] 2008 Oct; Vol. 30 (10), pp. 1806-16. |
| Publication Type: | Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print Cited Medium: Print ISSN: 0149-2918 (Print) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 19014836 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burge+DJ%22">Burge DJ</searchLink>; Trubion Pharmaceuticals Inc., Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Bookbinder+SA%22">Bookbinder SA</searchLink><br /><searchLink fieldCode="AU" term="%22Kivitz+AJ%22">Kivitz AJ</searchLink><br /><searchLink fieldCode="AU" term="%22Fleischmann+RM%22">Fleischmann RM</searchLink><br /><searchLink fieldCode="AU" term="%22Shu+C%22">Shu C</searchLink><br /><searchLink fieldCode="AU" term="%22Bannink+J%22">Bannink J</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227706726%22">Clinical therapeutics</searchLink> [Clin Ther] 2008 Oct; Vol. 30 (10), pp. 1806-16. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Excerpta+Medica%22">Excerpta Medica </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7706726 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0149-2918 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201492918%22">01492918 </searchLink><i>NLM ISO Abbreviation: </i>Clin Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19014836 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clinthera.2008.10.017 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1806 Titles: – TitleFull: Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burge DJ – PersonEntity: Name: NameFull: Bookbinder SA – PersonEntity: Name: NameFull: Kivitz AJ – PersonEntity: Name: NameFull: Fleischmann RM – PersonEntity: Name: NameFull: Shu C – PersonEntity: Name: NameFull: Bannink J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2008 Oct Type: published Y: 2008 Identifiers: – Type: issn-print Value: 0149-2918 Numbering: – Type: volume Value: 30 – Type: issue Value: 10 Titles: – TitleFull: Clinical therapeutics Type: main |
| ResultId | 1 |
